PHARMNOVO UK LTD

CH48 8DA (North West)

Start Date End Date Funded Value Relevance

CSV

25 50 100

£165,761

Feb 17 - Jan 18

Development of small peptide CGRP antagonists for migraine therapy

Innovate UK award to PHARMNOVO UK LTD and David A. Kendall

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}